NDAORALSOLUTION
Approved
Nov 2017
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
3
Data completeness
6/8 — Strong
CLENPIQ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) by Ferring Pharmaceuticals is acidifying activity [moa]. First approved in 2017.
Drug data last refreshed 4h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CLENPIQ is an oral solution combining sodium picosulfate, magnesium oxide, and anhydrous citric acid for bowel preparation prior to colonoscopy. It works through acidifying activity to cleanse the colon, enabling improved visualization during endoscopic procedures. The product represents a formulation innovation in the established bowel prep market.
$0.033BPart D
PeakStable
11.2 years to LOEProduct is at peak lifecycle stage with established market presence and meaningful claims volume, indicating stable, mature commercial operations.
Mechanism of Action
Acidifying Activity
Pharmacologic Class:
Calculi Dissolution Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
Started Jun 2022
39 enrolled
Bowel Preparation
Effects and Tolerability With Clenpiq and Low Residue Diet
Started Nov 2019
154 enrolled
Colonoscopy Preparation
Comparison of Clenpiq vs Golytely Bowel Preparation
Started Jul 2018
14 enrolled
Bowel Preparation Solutions
Career Relevance
Working on CLENPIQ offers career opportunities primarily in commercial, finance, and quality operations rather than R&D or medical innovation roles. The product's peak-stage maturity means positions focus on market maintenance, cost management, and regulatory compliance rather than expansion or launch activities.
Worked on CLENPIQ at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.